Mountain Crest Acquisition

YTD

ALL

Why Robinhood?

You can watch MCAD and buy or sell other stocks, ETFs, and their options commission-free!

About MCAD

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2015

Founded2015

Employees

—

Employees—

MCAD Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

695.80

Average volume695.80

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.001

52 Week high$0.001

52 Week low

—

52 Week low—

Stock Snapshot

With a market cap of 100, Mountain Crest Acquisition(MCAD) trades at $10.43.

During the trading day, Mountain Crest Acquisition(MCAD) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Mountain Crest Acquisition(MCAD) stock has reached 0, versus its average volume of 695.8.

People also own

Based on the portfolios of people who own MCAD. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.